The Risk of Recurrence in Breast Cancer Patients Treated with Tamoxifen: Polymorphisms of CYP2D6 and ABCB1-Reference-Cited by-同舟云学术

The Risk of Recurrence in Breast Cancer Patients Treated with Tamoxifen: Polymorphisms of CYP2D6 and ABCB1

Published:2011-12-20 Issue:1 Volume:14 Page:52-59
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Teh L. K.,Mohamed N. I.,Salleh M. Z.,Rohaizak M.,Shahrun N. S.,Saladina J. J.,Shia J. K. S.,Roslan H.,Sood S.,Rajoo T. S.,Muniandy S. P.,Henry G.,Ngow H. A.,Hla U K. T.,Din J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1208/s12248-011-9313-6.pdf

Reference37 articles.

1. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Insts. 1998;90:1371–88.

2. Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998;339:1609–18.

3. Girault I, Bi'eche I, Lidereau R. Role of estrogen receptor transcriptional. Coregulators in tamoxifen resistance in breast cancer. Maturitas. 2006;54:342–51.

4. Lim HS, Ju Lee H, Seok Lee K, Sook Lee E, Jang IJ, Ro J. Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer. J Clin Oncol. 2007;25:3837–45.

5. Goetz MP, Knox SK, Suman VJ, Rae JM, Safgren SL, Ames MM, et al. The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat. 2007;101:113–21.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PK/TK Considerations of Xenobiotic Metabolism Mechanisms and Rate Equations;Handbook of Pharmacokinetics and Toxicokinetics;2023-07-03

2. Genotypic variations of the CYP2D6 gene in patients with breast cancer treated with tamoxifen: case series;European Journal of Oncology Pharmacy;2023-07

3. CYP2D6 pharmacogenetics and phenoconversion in personalized medicine;Expert Opinion on Drug Metabolism & Toxicology;2022-11-02

4. The risk of relapse in breast cancer patients is associated with MMP-9 gene polymorphism: a prospective study in a sample of the Iranian population;Nucleosides, Nucleotides & Nucleic Acids;2022-07-01

5. Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing;Frontiers in Pharmacology;2022-06-30